Monitor for any future 13D conversion or increased activism from any of the recent institutional filers, though all current filings certify passive intent.
YARW drugs
YARW drug pipeline →Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Ameriprise Financial disclosed an 8.6% passive beneficial ownership stake in Yarrow Bioscience as of September 30, 2026, primarily through its Columbia Small Cap Growth Fund (6.3%). This adds to a series of recent 13G filings by other institutions following Yarrow's September 2026 equity offering, with no activist intent indicated.
Key Financial Metrics
Key Facts
- Ameriprise Financial, Inc. disclosed a 8.6% beneficial ownership stake in Yarrow Bioscience as of September 30, 2026.
- The stake comprises 739,538 shares of common stock, with 539,115 shares held by Columbia Small Cap Growth Fund (6.3%).
- The filing is a passive Schedule 13G under Rule 13d-1(b), certifying no intent to influence control.
- This follows recent 13G filings by Bellevue Group (10.6%), Spruce Street Capital (6.4%), and others after Yarrow's $172.5M September 2026 equity offering.
Financial Impact
8.6% passive stake valued at approximately $15.7M based on $183M market cap
Risk Factors
- No activist intent is indicated, but a cluster of institutional filings could precede coordinated engagement.
- Yarrow is a pre-revenue clinical-stage biotech with high cash burn and no approved products.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001193125-26-462440 |
| Document: 0001193125-26-462440.txt | 0001193125-26-462440 |
Track record
13 reports on YARW
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 17, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $14.20 Now $14.27 +0.49% settles Dec 16
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
- Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $15.44 Now $14.27 −7.58% settles Dec 15
- Nov 16, 20261d ago SC 13G Neutral 3/10 Viewing Entry $18.20 Now $14.27 −21.59% settles Dec 15
- Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $18.03 Now $14.27 −20.85% settles Dec 15
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $17.35 Now $14.27 −17.75% settles Dec 15
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $18.03 Now $14.27 −20.85% settles Dec 15
- Nov 12, 20265d ago 8-K Neutral 4/10 Entry $19.63 Now $14.27 −27.31% settles Dec 11
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers